Millennium Management
GTHX icon

Millennium Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Millennium Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-445,912
Closed -$1.93M – 6694
2024
Q1 		$1.93M Buy
445,912
+414,866
+1,336% +$1.45M ﹤0.01% 3771
2023
Q4 		$94.7K Sell
31,046
-1,017,949
-97% -$1.91M ﹤0.01% 5359
2023
Q3 		$1.51M Buy
1,048,995
+440,930
+73% +$853K ﹤0.01% 3831
2023
Q2 		$1.51M Sell
608,065
-267,069
-31% -$730K ﹤0.01% 3711
2023
Q1 		$2.34M Sell
875,134
-796,725
-48% -$3.83M ﹤0.01% 3283
2022
Q4 		$9.08M Buy
1,671,859
+499,363
+43% +$4.18M 0.01% 2240
2022
Q3 		$14.6M Buy
1,172,496
+444,376
+61% +$5.08M 0.01% 1680
2022
Q2 		$3.6M Buy
728,120
+603,926
+486% +$3.34M ﹤0.01% 3128
2022
Q1 		$944K Buy
124,194
+59,630
+92% +$565K ﹤0.01% 4591
2021
Q4 		$659K Buy
+64,564
New +$823K ﹤0.01% 4798
2021
Q1 		– Sell
-142,237
Closed -$2.56M – 6608
2020
Q4 		$2.56M Sell
142,237
-413,700
-74% -$6.18M ﹤0.01% 3036
2020
Q3 		$6.42M Buy
+555,937
New +$9.18M 0.01% 1618
2020
Q2 		– Sell
-137,024
Closed -$1.51M – 4699
2020
Q1 		$1.51M Sell
137,024
-31,030
-18% -$579K ﹤0.01% 2208
2019
Q4 		$4.44M Sell
168,054
-118,700
-41% -$2.78M 0.01% 2031
2019
Q3 		$6.53M Buy
286,754
+158,094
+123% +$4.98M 0.01% 1594
2019
Q2 		$3.94M Sell
128,660
-23,714
-16% -$499K 0.01% 1954
2019
Q1 		$2.53M Buy
152,374
+138,353
+987% +$2.62M ﹤0.01% 2254
2018
Q4 		$269K Buy
+14,021
New +$525K ﹤0.01% 3267
2018
Q2 		– Sell
-17,797
Closed -$659K – 4266
2018
Q1 		$659K Buy
+17,797
New +$475K ﹤0.01% 2908
2017
Q3 		– Sell
-108,145
Closed -$1.89M – 3949
2017
Q2 		$1.89M Buy
+108,145
New +$1.89M ﹤0.01% 2103

Other funds holding GTHX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Raymond James & Associates
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management's GTHX Position: Q2 2024 in Review

Millennium Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2024, closing a stake of 445,912 shares — an estimated $1.93M sold.

Millennium Management first reported a position in GTHX in Q2 2017 and held it in 20 quarters. The position peaked at $14.6M in Q3 2022. 88 funds tracked by Wall St. Rank hold GTHX as of Q2 2024.

  • Millennium Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 445,912 G1 Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $1.93M.
  • Millennium Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2017 and held it in 20 quarters.
  • Millennium Management's G1 Therapeutics, Inc. Common Stock position peaked at $14.6M in Q3 2022.
  • 88 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.